El acceso a la versión del editor puede requerir la suscripción del recurso Access to the published version may require subscription The preparation and characterization of three novel 4 N-monosubstituted bis(thiosemicarbazone) Q1 ligands of 3,5-diacetyl-1,2,4-triazol series and their dinuclear platinum complexes are described. The crystal and molecular structure of the [Pt(m-H 3 L 3 )] 2 complex derived of 3,5-diacetyl-1,2,4-triazol bis( 4 N-p-tolylthiosemicarbazone), H 5 L 3 , has been resolved by single crystal X-ray diffraction. The ligands coordinate, in an asymmetric dideprotonate form, to the platinum ions in a tridentate fashion (NNS) and S-bridging bonding modes. Thus the molecular units of the platinum complexes are stacked as dimers. The new compounds synthesized have been evaluated for antiproliferative activity in vitro against NCI-H460, A2780 and A2780cisR human cancer cell lines. The cytotoxicity data suggest that these compounds may be endowed with important antitumour properties since are capable of not only circumventing cisplatin resistance in A2780cisR cells but also exhibit high antiproliferative activity in human non-small cell lung cancer NCI-H460 cells. The interactions of these compounds with calf thymus DNA was investigated by UV-vis absorption and a nephrotoxic study, in LLC-PK1 cells, has also been carried out.
Introduction
Although platinum metallo-drugs are among the most effective agents for the treatment of cancer its clinical utility is restricted due to the frequent development of drug resistance, the limited spectrum of tumours against which these drugs are active and 5 severe normal tissue toxicity, including nephrotoxicity, being an important side effect which interferes with their therapeutic efficiency.
1-5
These disadvantages have driven the development of improved platinum-based anticancer drugs but, the great majority of 10 antitumour metal complexes synthesized are structural analogs of cisplatin and it has been demonstrated that these compounds having similar DNA-binding modes also exhibit similar biological profiles. Therefore, there is a considerable interest in the synthesis and 15 characterization of new structural types of compounds whose structure and mode of action differ from that of cisplatin.
6-9 In this regard, and taking into account that one of the mechanisms inducing the nephrotoxicity is due to the inactivation of some enzymes because of the reaction between platinum ions and sulfur 20 containing proteins, an active area of research focuses on the synthesis of chelate platinum(II) complexes bearing nitrogen and sulfur mixed donor atoms, which should prevent the adverse reaction described.
10,11
a-(N)-Heterocyclic thiosemicarbazones, (N)-TSCs, are typical 25 tridentate NNS chelate ligands and moreover some of them have shown antineoplastic activity by themselves. 12 It has been demonstrated that the biochemical mechanism of action involves, among others, ribonucleotide reductase (RR) inhibition and DNA interaction by intercalation. Particularly, the 3-aminopyridine-2-30 carboxaldehyde thiosemicarbazone (Triapine, Vion Pharmaceuticals, New Haven, CT) is currently being screened for antitumour effects using the National Cancer Institute panel of 60 tumour cell lines and selected for Phase I and II clinical trials.
13-15
For thiosemicarbazone/metal compounds, several mechanisms 35 of antitumour action have also been proposed. For example, they a) could interact with DNA by formation of a metal-DNA covalent bond, b) could interfere in the DNA synthesis by RR inhibition, and c) could interact with DNA through non-covalent interactions including H-bonding and intercalation. 3 )] 2 , thus, the n(NH-triazol) disappears in the spectra of platinum complexes as consequence of the deprotonation of the triazole ring. Regarding the typical bands from the thioamide group, 18 -NH-C(S)-, which are expected to 45 be affected differently by different modes of coordination after complexation with metal ions, the band corresponding to n(C S) disappears upon complexation indicating coordination via the thioamide sulfur atom. On the other hand, coordination only induces minor changes in n(C N). 50 In the 1 H NMR spectra of the ligands, the triazolic proton was observed as a singlet between 15.09 and 15.28 ppm and two independent singlets at~12.9 and~11.3 ppm were observed for 2 N-hydrazinic hydrogens suggesting the presence of the Z (sulfur atom cis to the azomethine nitrogen atom) and E (sulfur atom 55 trans to the azomethine nitrogen atom) structural isomers in solution in accordance with data reported in the literature for other thiosemicarbazones.
19 It may be surprising that these three signals remain in the spectra of the dimeric dideprotonated complexes, however this fact can be explained taking in account that the 60 complexes are dimeric and contain four thiosemicarbazone arms which can exist, in solution, in various tautomeric forms (asymmetric dideprotonation, or symmetric deprotonation) forming both intra-and intermolecular hydrogen bonds. 
2.023(7) Pt(2)-N (13) 2.054 (7) These spectroscopic similarities suggest the same dimeric structure for the three platinum(II) complexes synthesized.
Description of the crystal structure
Good quality crystals suitable for single crystal X-ray diffraction analysis were obtained for [Pt(m-H 3 L
3 )] 2 by recrystallization 5 in dimethylsulfoxide (DMSO). The molecular structure of the platinum complex together with the atomic numbering scheme is shown in Fig. 1 . Crystallographic data is shown in Table 1 with selected bond lengths shown in Table 2 . This neutral platinum(II) dinuclear compound crystallizes in 10 the triclinic P1 space group with Z = 2 and its crystallographic analysis reveals unambiguously a dimeric structure which results from the pairing of two mononuclear subunits through two thiosemicarbazone moieties bridges.
Each Pt(II) center is four coordinated with a [NNSS] donor 15 environment, via: one triazolic nitrogen atom, the iminic nitrogen and sulfur atoms belonging to the deprotonated arm of one ligand molecule, and the fourth position being occupied by a sulfur atom of the non-deprotonated arm from the other ligand. Thus, the deprotonated thiosemicarbazone arm behaves as a bidentate and 20 the neutral one behaves as a monodentate acting as a bridge.
The bond angle data indicates that the stereochemistry around Q4 each platinum(II) ion is almost planar. The angles deviate slightly from that expected for a regular square-planar geometry, this distortion may be attributed to the restricted bite angle of the 25 tridentate moieties. The coordination results in the formation of two five membered (PtSCNN and PtSCNN) chelate rings for each platinum(II) ion, which are coplanar with the deprotonated triazole ring. by intermolecular p-p stacking interactions between successive thiosemicarbazone moieties (3.78 Å ) that give rise to the environment for the structure that is represented in Fig. 2 .
Antiproliferative activity in human NCI-H460, A2780 and A2780cisR cell lines 10
To analyze the potential of the compounds as antitumour agents, the new compounds synthesized were tested (in powder solid form) for their antiproliferative activity in vitro against the human cancer cell lines: NCI-H460 (non-small cell lung cancer), A2780 and A2780cisR (ephileian ovarian cancer). For comparison 15 purposes the cytotoxicity of cisplatin was evaluated under the same experimental conditions. 
DNA Binding Studies
To study the binding affinity between DNA and the new ligands and platinum(II) complexes, which have significant effect 15 against the tested cell lines, the UV absorption spectroscopy has been a very useful technique because the typical B-form DNA gives rise to a characteristic band at 260 nm in UV region. Hyperchromism (increase in absorption of the DNA band) and hypochromism (decrease in absorption of the DNA band) are 20 the spectral changes typical of a compound interaction with the DNA helix. Hypochromism results from contraction of the DNA helix as well as changes in its conformation, while hyperchromism results from damage to the DNA double helix structure. 24 
25
In UV experiments, the spectra of CT-DNA in the presence of each compound have been recorded, by keeping constant CT-DNA concentrations in diverse [CT-DNA]/[compound] mixing ratios (R = 1-10) and monitoring the change in the absorption intensity of the typical CT-DNA spectral band at 260 nm. 30 In the absence of CT-DNA, both ligands and complexes displayed intense absorptions bands in the UV region (l max 295-323 nm) assigned to intraligand p → p* transitions of aromatic chromophores which are also sensitive to the interaction of the compound with CT-DNA. 35 For all compounds, the absorption spectra displayed an increase in the intensity of the characteristic CT-DNA absorbance while increasing the compound concentration, and the percentage of hyperchromism observed is given in Table 4 . Only in the spectrum of H 5 L 1 ligand, the hyperchromism is accompanied by a red-shift 40 up to 275 nm. In addition, the absorption spectra of the three ligands show an increase of the intensity of the ligand centered transitions, and these changes are also more pronounced in the case of H 5 L 1 ligand for which the band at l max 322 nm is split into three bands at l max 327, 241 and 357 nm (Fig. 3) . 45 These characteristics suggest noncovalent interactions such as electrostatic and surface (major or minor groove) binding along the outside of the DNA helix. Intercalative DNA-binding has been excluded on the basis of the absence of hypochromism; in the other hand both ligands and platinum(II) complexes show similar UV 50 absorption profiles therefore a covalent interaction between Pt(II) and guanine N7 is unlikely.
Preliminary nephrotoxicity studies
In order to investigate possible adverse side effects that may occur, such as nephrotoxicity, the compounds were subsequently tested 55 (in powder solid form) in vitro on normal human renal LLC-PK1 cells. For comparison purposes the toxicity of cisplatin was evaluated under the same experimental conditions. As is shown in 
Experimental Measurements 25
Elemental analyses were performed on a LECO CHNS-932 microanalyzer. Fast atom bombardment (FAB) mass spectra were performed on a VG AutoSpec spectrometer (nitrobenzyl alcohol matrix).
1 H NMR spectra (DMSO-d 6 ) were recorded on a BRUKER AMX-300 spectrometer. All cited physical measure-30 ments were obtained out by the Servicio Interdepartamental de Investigación (SIDI) of the Universidad Autónoma de Madrid. Melting points were determined with a Stuart Scientific SMP3 apparatus. Conductivity measurements were made on a Crison Basic 30+ conductimeter. Infrared spectra (KBr pellets) were 35 recorded on a Bomen-Michelson spectrophotometer (4000-400 cm -1 ). Electronic spectra were recorded on an Unicam UV/vis UV4 spectrophotometer.
Materials
Solvents were purified and dried according to standard procedures. 40
Hydrazine hydrate, L-lactic acid, ortho-tolyl isothiocyanate, metatolyl isothiocyanate, para-tolyl isothiocyanate and potassium tetrachloridoplatinate(II) were commercially available. Calf thymus DNA (CT-DNA), Tris-HCl and NaCl were purchased from Aldrich. 45
Synthesis of compounds 3,5-Diacetyl-1,2,4-triazol bis(
4 N-tolylthiosemicarbazone) ligands. The thiosemicarbazides were prepared by reacting an ethanolic solution of the desired (ortho, meta or para) tolylisothiocyanate with an ethanolic solution of hydrazine hydrate, in a 50 1 : 1 molar ratio. The reaction mixture was stirred for one more hour and then the white product formed was filtered, washed with ethanol and diethyl ether, dried in vacuo and recrystallised from ethanol. The thiosemicarbazones were obtained by refluxing an ethanolic 55 solution (20 mL) of the desired 4 N-tolylthiosemicarbazide (2 mmol) with 3,5-diacetyl-1,2,4-triazol (1 mmol), which was prepared as described in reference, 25 for five hours and then was left to stand to ambient temperature. The solution was reduced to half volume and the pale yellow solid formed was filtered, washed with 60 cold ethanol and diethyl ether and dried in vacuo. 
In vitro antiproliferative activity
The human cancer cells (A2780, A2780cisR and NCI-H460) were grown in RPMI-1640 medium supplemented with 10% foetal bovine serum (FBS) and 2 mM L-glutamine in an atmosphere of 5% CO 2 at 37
• C. Cell proliferation was evaluated by the 55 sulforhodamine B assay. Cells were plated in 96-well sterile plates at a density of 15 ¥ 10 3 (for NCI-H460) or 4000 (for A2780 and A2780cisR) cells per well with 100 mL of medium and were then incubated for 24 h. After attachment to the culture surface the cells were incubated with various concentrations of the compounds 60 tested freshly dissolved in DMSO (1 mg mL -1 ) and diluted in the culture medium (DMSO final concentration 1%) for 48 h (for NCI-H460) or 96 h (for A2780 and A2780cisR). The cells were fixed by adding 50 mL of 30% trichloroacetic acid (TCA) per well. The plates were incubated at 4
• C for 1 h and then washed five 65 times with distilled water. The cellular material fixed with TCA was stained with 0.4% sulforhodamine B dissolved in 1% acetic acid for 10 min. Unbound dye was removed by rinsing with 0.1% acetic acid. The protein-bound dye was extracted with 10 mM unbuffered Tris base for determination of optical density (at 515 70 nm) in a Tecan Ultra Evolution spectrophotometer.
The normal human cells (LLC-PK1) were grown in 199 medium supplemented with 3% foetal bovine serum (FBS) and 1.5 g L -1
of sodium bicarbonate in an atmosphere of 5% CO 2 at 37
• C. Cell proliferation was evaluated by the sulforhodamine B assay. 75 Cells were plated in 96-well sterile plates at a density of 10,000 cells per well with 100 mL of medium and were then incubated for 24 h. After attachment to the culture surface the cells were incubated with various concentrations of the compounds tested freshly dissolved in DMSO (1 mg mL -1 ) and diluted in the culture 80 medium (DMSO final concentration 1%) for 48 h at 37
• C. The cells were fixed by adding 50 mL of 30% trichloroacetic acid (TCA) per well. The plates were incubated at 4
• C for 1 h and then washed five times with distilled water. The cellular material fixed with TCA was stained with 0.4% sulforhodamine B dissolved in 1% acetic 85 acid for 10 min. Unbound dye was removed by rinsing with 0.1% acetic acid. The protein-bound dye was extracted with 10 mM unbuffered Tris base for determination of optical density (at 515 nm) in a Tecan Ultra Evolution spectrophotometer.
The effects of complexes were expressed as corrected percentage 90 inhibition values according to the following equation:
where T is the mean absorbance of the treated cells and C the mean absorbance in the controls.
The inhibitory potential of compounds was measured by cal-95 culating concentration-percentage inhibition curves, these curves were adjusted to the following equation:
where E is the percentage inhibition observed, E max is the maximal effects, IC 50 is the concentration that inhibits 50% of maximal 100 growth, C is the concentration of compounds tested and n is the slope of the semi-logarithmic dose-response sigmoid curves. This non-linear fitting was performed using GraphPad Prism 2.01 software.
30
For comparison purposes, the antiproliferative activity of 105 cisplatin was evaluated under the same experimental conditions. All compounds were tested in two independent studies with triplicate points. These experiments were carried out at the Unidad de Evaluación de Actividades Farmacológicas de Compuestos Químicos (USEF), Universidad de Santiago de Compostela.
DNA-Binding experiments
CT-DNA stock solution was prepared by dissolving the lyophilized sodium salt in Tris-buffer (NaCl 50 mM, Tris-HCl 5 mM, pH was adjusted to 7.3 with NaOH 0.5 M) by stirring at 4
• C for 2 days. The CT-DNA solution was standardized spectrophotometrically 31 by using its known molar absorption 5 coefficient at 260 nm (6600 M -1 cm -1 ). The ratio of UV absorbance at 260 and 280 nm, A 260 /A 280 , of ca. 1.8, indicating that the DNA was sufficiently free of protein. Stock solutions were kept frozen until the day of the experiment.
Concentrated stock solutions (5 ¥ 10 -3 M) of both ligands 10 and platinum(II) complexes were prepared dissolving each one of the compounds in DMSO. From these stock solutions, for all experiments the desired concentration of compound was achieved by dilution with Tris-buffer (NaCl 50 mM, Tris-HCl 5 mM, pH was adjusted to 7.3 with NaOH 0.5 M) to give homogeneous 15 solutions with a DMSO content of less than 2.5%. In order to prepare the adducts with double-stranded CT-DNA, to a mixture of a fixed amount of CT-DNA (1 ¥ 10 • C, and the their UV-vis absorption spectra were recorded, at room temperature, in the wavelength interval of 240-400 nm.
